Hospitalizations Are Increasing Among Minority Patients with Crohn's Disease and Ulcerative Colitis

被引:45
|
作者
Sewell, Justin L. [1 ]
Yee, Hal F., Jr.
Inadomi, John M.
机构
[1] Univ Calif San Francisco, GI HOPE Res Program, San Francisco, CA 94143 USA
关键词
epidemiology; minority studies; ulcerative colitis; general clinical; Crohn's disease; INFLAMMATORY-BOWEL-DISEASE; CLINICAL EPIDEMIOLOGY; CHINESE POPULATION; UNITED-STATES; RATES; AMERICANS; TRENDS;
D O I
10.1002/ibd.21008
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Rates of inflammatory bowel disease (IBD) appear to be increasing among nonwhite populations outside the United States, but national data describing the incidence and prevalence of IBD are not available for minority patients. The aim of this study was to examine time trends of hospital discharge among minority patients with IBD. Methods: Nationally representative data describing hospital discharges were obtained from the National Hospital Discharge Survey for the years 1994 to 2006. Race-specific annual proportions of hospitalizations including a discharge diagnosis of ulcerative colitis and Crohn's disease were calculated. Trends in proportions were assessed for statistical significance using the extended Mantel-Haenszel chi-square test for trend. Results: The proportion of hospitalizations including a discharge diagnosis of IBD increased significantly from 1994 to 2006 among the total population and among Asian, black, and white patients separately. Increases were statistically significant when analysis was performed for Crohn's disease and ulcerative colitis combined and separately. Marked increases were seen among Asians. Conclusions: The proportion of hospitalizations including a discharge diagnosis of IBD increased significantly among minority and nonminority patients from 1994 through 2006. The causes underlying these changes are not certain and should be further investigated.
引用
收藏
页码:204 / 207
页数:4
相关论文
共 50 条
  • [31] Cancer in patients with ulcerative colitis, Crohn's disease and coeliac disease: record linkage study
    Goldacre, Michael J.
    Wotton, Clare J.
    Yeates, David
    Seagroatt, Valerie
    Jewell, Derek
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2008, 20 (04) : 297 - 304
  • [32] Metaproteomics of fecal samples of Crohn's disease and Ulcerative Colitis
    Lehmann, T.
    Schallert, K.
    Vilchez-Vargas, R.
    Benndorf, D.
    Puettker, S.
    Sydor, S.
    Schulz, C.
    Bechmann, L.
    Canbay, A.
    Heidrich, B.
    Reichl, U.
    Link, A.
    Heyer, R.
    JOURNAL OF PROTEOMICS, 2019, 201 : 93 - 103
  • [33] Current position on Vedolizumab for ulcerative colitis and Crohn's disease
    Schreiber, S.
    Dignass, A. U.
    Hartmann, H.
    Kruis, W.
    Rogler, G.
    Siegmund, B.
    Stallmach, A.
    Witte, C.
    Bokemeyer, B.
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2015, 53 (06): : 591 - 602
  • [34] A comparison of diverticulitis in Crohn's disease versus ulcerative colitis
    Persaud, Alana
    Ahmed, Ahmed
    Kakked, Gaurav
    Shulik, Oleg
    Ahlawat, Sushil
    JGH OPEN, 2019, 3 (06): : 508 - 512
  • [35] Diagnosis of Crohn's disease and ulcerative colitis using the microbiome
    Kang, Da-Yeon
    Park, Jong-Lyul
    Yeo, Min-Kyung
    Kang, Sang-Bum
    Kim, Jin-Man
    Kim, Ju Seok
    Kim, Seon-Young
    BMC MICROBIOLOGY, 2023, 23 (01)
  • [36] New biologic therapeutics for ulcerative colitis and Crohn's disease
    Mozaffari, Shilan
    Nikfar, Shekoufeh
    Abdolghaffari, Amir Hossein
    Abdollahi, Mohammad
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2014, 14 (05) : 583 - 600
  • [37] Is there a role for vedolizumab in the treatment of ulcerative colitis and Crohn's disease?
    Gilroy, Leah
    Allen, Patrick B.
    CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY, 2014, 7 : 163 - 172
  • [38] Differentially Expressed miRNAs in Ulcerative Colitis and Crohn's Disease
    Yarani, Reza
    Shojaeian, Ali
    Palasca, Oana
    Doncheva, Nadezhda T.
    Jensen, Lars Juhl
    Gorodkin, Jan
    Pociot, Flemming
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [39] Safety of vedolizumab in the treatment of Crohn's disease and ulcerative colitis
    Hagan, Matilda
    Cross, Raymond K.
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (09) : 1473 - 1479
  • [40] Crohn's Disease after Proctocolectomy and IPAA for Ulcerative Colitis
    Hercun, Julian
    Cote-Daigneault, Justin
    Lahaie, Raymond G.
    Richard, Carole
    Wassef, Ramses
    Poitras, Pierre
    DISEASES OF THE COLON & RECTUM, 2021, 64 (02) : 217 - 224